COVID-19 and Vaccination Attitudes (VACAT)

November 11, 2020 updated by: Blanchard-Rohner Geraldine, University Hospital, Geneva
The investigators want to study how the exposure to the covid-19 pandemic affects attitudes towards science and vaccination, and how other general attitudes and values are affected.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators will carry out a survey in the UK, asking the same 3 questions on vaccination as in a past survey in late 2019 to the same previous respondents, supplementing this with further questions on covid-19 exposure and attitudes towards, among others, individualism-collectivism, health policy as well as trust in science and institutions.

Study Type

Observational

Enrollment (Actual)

1194

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Representative sample of UK population

Description

Inclusion Criteria:

  • All volunteers who participated in the November 2019 survey on vaccination will be contacted.

Exclusion Criteria:

  • People who have not participated in the November 2019 survey
  • People unwilling to participate again

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Survey respondants
Other: Survey
Survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
How vaccination and other attitudes are affected by COVID
Time Frame: Over last six months
Survey
Over last six months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Geneva

Collaborators

University of Zurich
University of Lausanne

Investigators

  • Principal Investigator: Geraldine Blanchard-Rohner, MD-PhD, University Hospital, Geneva

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2020

Primary Completion (Actual)

April 30, 2020

Study Completion (Actual)

April 30, 2020

Study Registration Dates

First Submitted

April 13, 2020

First Submitted That Met QC Criteria

April 15, 2020

First Posted (Actual)

April 20, 2020

Study Record Updates

Last Update Posted (Actual)

November 13, 2020

Last Update Submitted That Met QC Criteria

November 11, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VACAT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Replication data to be shared yet anonymized

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19

Clinical Trials on Survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe